These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22498682)

  • 1. [Introduction to Good Manufacturing Practice for investigational agents].
    Sakakibara T
    Nihon Yakurigaku Zasshi; 2012 Apr; 139(4):170-3. PubMed ID: 22498682
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 3. Manufacturing uncertainty: adverse effects of drug development for women.
    Peppin P
    Int J Law Psychiatry; 2003; 26(5):515-32. PubMed ID: 14522223
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Contribution of GMP-grade Hospital Preparation to Translational Research].
    Yonezawa A; Kajiwara M; Minami I; Omura T; Nakagawa S; Matsubara K
    Yakugaku Zasshi; 2015; 135(8):943-7. PubMed ID: 26234351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaceutical quality and good manufacturing practices (author's transl)].
    Traisnel
    J Pharm Belg; 1980; 35(3):233-7. PubMed ID: 7400928
    [No Abstract]   [Full Text] [Related]  

  • 6. A timely re-examination of drug polymorphism in pharmaceutical development and regulation.
    Grant DJ; Byrn SR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):237-9. PubMed ID: 14962580
    [No Abstract]   [Full Text] [Related]  

  • 7. China's perspective on similar biotherapeutic products.
    Liang C; Wang J
    Biologicals; 2011 Sep; 39(5):312-6. PubMed ID: 21924622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Approval of clinical trials with biological medicinal products].
    Gross S; Jost N; Hartmann JP
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):826-829. PubMed ID: 28677049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosimilars and safety issues.
    Dammacco F; Abbracchio MP; Gesualdo L; Goffredo F; Ronco C; Zanella A
    Leuk Lymphoma; 2009 Apr; 50(4):656-8. PubMed ID: 19373667
    [No Abstract]   [Full Text] [Related]  

  • 10. Biosimilars: considerations for an abbreviated pathway.
    Kozlowski S; Behrman R
    Leuk Lymphoma; 2009 Apr; 50(4):527-8. PubMed ID: 19373649
    [No Abstract]   [Full Text] [Related]  

  • 11. Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference.
    Yu LX; Baker J; Berlam SC; Boam A; Brandreth EJ; Buhse L; Cosgrove T; Doleski D; Ensor L; Famulare J; Ganapathy M; Grampp G; Hussong D; Iser R; Johnston G; Kesisoglou F; Khan M; Kozlowski S; Lacana E; Lee SL; Miller S; Miksinski SP; Moore CM; Mullin T; Raju GK; Raw A; Rosencrance S; Rosolowsky M; Stinavage P; Thomas H; Wesdyk R; Windisch J; Vaithiyalingam S
    AAPS J; 2015 Jul; 17(4):1011-8. PubMed ID: 25840884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organization Expert Committee
    World Health Organ Tech Rep Ser; 2010; (957):1-276, back cover. PubMed ID: 20560300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What should the anaesthetist know about current laws on medical products?].
    Kaiser R; Ininger G; Stösslein E
    Anaesthesist; 2003 Apr; 52(4):363-73; quiz 373-4. PubMed ID: 12760343
    [No Abstract]   [Full Text] [Related]  

  • 15. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging Technology as a Key Enabler for Modernizing Pharmaceutical Manufacturing.
    Lee SL; Brorson K
    PDA J Pharm Sci Technol; 2017; 71(2):66-67. PubMed ID: 28396563
    [No Abstract]   [Full Text] [Related]  

  • 17. Manufacturing of biodrugs: need for harmonization in regulatory standards.
    Sahoo N; Choudhury K; Manchikanti P
    BioDrugs; 2009; 23(4):217-29. PubMed ID: 19697964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous Manufacturing in Pharmaceutical Process Development and Manufacturing.
    Burcham CL; Florence AJ; Johnson MD
    Annu Rev Chem Biomol Eng; 2018 Jun; 9():253-281. PubMed ID: 29879381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.